Cystic Fibrosis. Jennifer McDaniel, BS, RRT-NPS
|
|
- Nathaniel Rodgers
- 6 years ago
- Views:
Transcription
1 Cystic Fibrosis Jennifer McDaniel, BS, RRT-NPS
2 Overview Cystic fibrosis is the most common fatal, inherited disease in the U. S. CF results from a defective autosomal recessive gene One copy of gene = carrier Codes for a protein responsible for salt transport by epithelial cells Defective gene found on chromosome #7 Several hundred mutations possible ~12 mutations identified, delta F508 most common (68%)
3 Overview Genetic defect expressed when two carriers produce progeny 25% chance of CF 50% chance of carriers 25% chance of normal Affects all racial and ethnic groups, but Caucasians of northern European ancestry most often affected
4 Statistics of CF Median age of survival 1960s: ~2-4 yrs Early 1990s: ~25 years 2000: ~30 years 2006: ~37 years Incidence 30,000 Americans, 20,000 Europeans, 3,000 Canadians In U. S., 12,000,000 carriers 2500 CF babies born annually in U. S.
5 Statistics of CF Incidence Caucasians: 1 in 1600 births African Americans: 1 in 13,000 births Asian Americans: 1 in 50,000 births 1 in 22 Caucasians are carriers
6 Genetics and Dysfunction Defective gene identified in 1989 Bichemical abnormality called cystic fibrosis transmembrane regulator (CFTR) Interferes with Cl - transport across epithelial membranes, primarily manifested in exocrine glands
7 Respiratory Related Conditions Repeated infections Chronic cough Recurrent bronchitis Recurrent pneumonia Bronchiectasis Pneumothorax Hemoptysis Digital clubbing Cor pulmonale Sinusitis Allergic bronchopulmonary asperigillosis Nasal polyps
8 Digital Clubbing
9 Chest X-Ray
10 Other Manifestations Gastrointestinal Failure to thrive Greasy, foul-smelling stools Meconium ileus Distal intestinal obstruction Hyperglycemia Abdominal discomfort Rectal prolapse Hepatobiliary System Liver disease Prolonged neonatal Jaundice Reproductive Tract Delayed puberty Infertility Sweat Glands High salt content
11 Diagnosis Genetic testing Sweat test Other Prenatal diagnosis Medical history Immunoreactive trypsinogen test Nasal potential difference measurement Pulmonary function testing
12 Pulmonary Infections Staphylococcus aureus (early) Pseudomonas aeruginosa Burkholderia cepacia
13 Sweat Chloride Test Use pilocarpine and a mild electrical current to promote sweat production Wrap with pad and plastic covering Collect and analyze sweat for chloride Positive test Cl - > 60 mmoles/l in children Cl - > 80 mmoles/l in adults
14 Treatment Antibiotics Improved nutrition Antiinflammatories Pancreatic enzyme supplements Bronchial hygiene Bronchodilators & mucolytics Physical therapy & exercise Lung transplantation
15 Airway Clearance Techniques Chest physical therapy Forced expiratory technique Active cycle breathing Positive expiratory pressure Autogenic drainage Flutter device Vest Exercise
16 Mucolytics Rh DNAse (Pulmozyme) Acetylcysteine (Mucomyst) Saline (nasal washes)
17 Lung Transplantation Limitations High cost Posttransplantation comlications Oliterative bronchiolitis (30% to 50% in 3-5 years) 1 year survival: ~72% 3 year survival: 55% 5 year survival: 49%
18 Lung Transplantation General criteria <60-65 years old No significant extrapulmonary complications No steroid regimen >20 mg prednisone daily No malignancy within past 5 years 20% of ideal body weight Ambulatory and capable of pretransplantation rehab program Motivated and likely to comply with regimen No smoking or drug/alcohol abuse No major psychiatric problems Adequate financial resources
19 Lung Transplantation Severity of disease criteria FEV 1 <30% PaO 2 < 55 mm Hg PaCO 2 > 50 mm Hg Suffering from an unacceptable quality of life
20 Lung Transplantation Potentially inadvisable situations Significant liver disease Severe malnourishment Extensive pleural scarring Ventilator dependent Colonized by Burkholderia cepacia Aspergilloma with extensive pleural reaction Severe osteoporosis with history of vertebral compression
21 Thoughts on Mechanical Ventilation Return to spontaneous ventilation is likely Not usually for end-stage condition
FACTS ABOUT. Cystic Fibrosis. What Is Cystic Fibrosis. What Are the Signs and Symptoms of CF?
FACTS ABOUT Cystic Fibrosis What Is Cystic Fibrosis Cystic fibrosis (CF) is a chronic, progressive, and frequently fatal genetic (inherited) disease of the body s mucus glands. CF primarily affects the
More informationFocus on Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis
Focus on (Relates to Chapter 29, Nursing Management: Obstructive Pulmonary Diseases, in the textbook) Copyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Autosomal recessive, multisystem
More informationCYSTIC FIBROSIS OBJECTIVES NO CONFLICT OF INTEREST TO DISCLOSE
CYSTIC FIBROSIS Madhu Pendurthi MD MPH Staff Physician, Mercy Hospital Springfield, MO NO CONFLICT OF INTEREST TO DISCLOSE OBJECTIVES Epidemiology of Cystic Fibrosis (CF) Genetic basis and pathophysiology
More informationA review of Cystic Fibrosis
A review of Cystic Fibrosis Jennifer Landry md F.R.C.P.(C) Pulmonary & Critical Care Medicine McGill University Health Center Cystic Fibrosis One of the most common lethal inherited AR disorders in the
More informationWhat is Cystic Fibrosis? CYSTIC FIBROSIS. Genetics of CF
What is Cystic Fibrosis? CYSTIC FIBROSIS Lynne M. Quittell, M.D. Director, CF Center Columbia University Chronic, progressive and life limiting autosomal recessive genetic disease characterized by chronic
More informationCystic Fibrosis. Parkland College. Monica Rahman Parkland College. Recommended Citation
Parkland College A with Honors Projects Honors Program 2013 Cystic Fibrosis Monica Rahman Parkland College Recommended Citation Rahman, Monica, "Cystic Fibrosis" (2013). A with Honors Projects. 98. http://spark.parkland.edu/ah/98
More informationCystic Fibrosis. Presented by: Chris Belanger & Dylan Medd
Cystic Fibrosis Presented by: Chris Belanger & Dylan Medd Outline What is Cystic Fibrosis? Signs, Symptoms & Diagnosis Who does it effect? General effects on daily life Managing Cystic Fibrosis Exercise
More information"Management and Treatment of Patients with Cystic fibrosis (CF)
"Management and Treatment of Patients with Cystic fibrosis (CF) Dr. Malena Cohen-Cymberknoh Pediatric Pulmonology and CF Center Hadassah Hebrew-University Medical Center Jerusalem, Israel Afula, March
More informationCystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012
Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012 INTRODUCTION PNEUMOTHORAX HEMOPTYSIS RESPIRATORY FAILURE Cystic Fibrosis Autosomal Recessive Genetically
More informationRespiratory Pharmacology: Treatment of Cystic Fibrosis
Respiratory Pharmacology: Treatment of Cystic Fibrosis Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart
More informationGoals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy
CYSTIC FIBROSIS Lynne M. Quittell, M.D. Director, CF Center Columbia University Goals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy What is Cystic Fibrosis? Chronic, progressive
More informationPATIENT EDUCATION. Cystic Fibrosis Carrier Testing
PATIENT EDUCATION Cystic Fibrosis Carrier Testing Introduction Cystic fibrosis carrier testing before or during pregnancy can help determine your risk of having a child with cystic fibrosis. This information
More informationOverview of Cystic fibrosis in children. Apeksha Sathyaprasad, MD Pediatric pulmonologist
Overview of Cystic fibrosis in children Apeksha Sathyaprasad, MD Pediatric pulmonologist No conflicts of interest OBJECTIVES Review pathophysiology of pulmonary disease in cystic fibrosis Review diagnostic
More informationFOR GENERAL PRACTITIONERS
INFORMATION PACK FOR GENERAL PRACTITIONERS Presented by 2 CONTENTS Chapter Page No 1. What is Cystic Fibrosis (CF)?... 5 Definition Symptoms The Digestive System Signs & Symptoms Breast Feeding & Cystic
More informationCystic fibrosis: hitting the target
Cystic fibrosis: hitting the target Heartland Collaborative Annual Meeting Friday, October 5, 2012 Thomas Ferkol MD 1938 1953 Cystic fibrosis: a historical timeline Cystic fibrosis (CF) of the pancreas
More informationChanges in the management of children with Cystic Fibrosis. Caroline Murphy & Deirdre O Donovan CF Nurses
Changes in the management of children with Cystic Fibrosis Caroline Murphy & Deirdre O Donovan CF Nurses What Is Cystic Fibrosis? Cystic fibrosis (CF) is an inherited chronic disease that primarily affects
More informationUNDERSTANDING CYSTIC FIBROSIS
UNDERSTANDING CYSTIC FIBROSIS INTRODUCTION Cystic fibrosis is a chronic disease that affects the respiratory and gastrointestinal systems. People with cystic fibrosis have a genetic defect of the lungs
More informationWhat is the inheritance pattern (e.g., autosomal, sex-linked, dominant, recessive, etc.)?
Module I: Introduction to the disease Give a brief introduction to the disease, considering the following: the symptoms that define the syndrome, the range of phenotypes exhibited by individuals with the
More information10/05/2017. Learning Objectives. Etiology and Prevalence. Diagnosis of Cystic Fibrosis. Disease of Childhood? Survival in Cystic Fibrosis
Management of the Cystic Fibrosis Patient Jessica Goggin, MAS, RN Nurse Manager UC San Diego Adult Cystic Fibrosis Program Learning Objectives 1. Describe the symptoms associated with Cystic Fibrosis (CF).
More informationChronic obstructive lung disease. Dr/Rehab F.Gwada
Chronic obstructive lung disease Dr/Rehab F.Gwada Obstructive lung diseases Problem is in the expiratory phase Lung disease Restrictive lung disease Restriction may be with, or within the chest wall Problem
More informationCystic Fibrosis Carrier Testing
PATIENT EDUCATION Cystic Fibrosis Carrier Testing Introduction Cystic fibrosis carrier testing before or during pregnancy can help determine your risk of having a child with cystic fibrosis. This information
More informationUK Cystic Fibrosis Registry
UK Cystic Fibrosis Registry Annual Data Report 2017 Scotland UK Cystic Fibrosis Registry 2017 Annual Data Report - Scotland Report prepared by Andrew Lee Statistician Cystic Fibrosis Trust Susan Charman
More informationEvaluation of Patients with Diffuse Bronchiectasis
Evaluation of Patients with Diffuse Bronchiectasis Dr. Patricia Eshaghian, MD Assistant Clinical Professor of Medicine Director, UCLA Adult Cystic Fibrosis Affiliate Program UCLA Division of Pulmonary
More informationBronchiectasis in Adults - Suspected
Bronchiectasis in Adults - Suspected Clinical symptoms which may indicate bronchiectasis for patients Take full respiratory history including presenting symptoms, past medical & family history Factors
More informationChronic lung diseases in children Simple choice 1. Finger clubbing is not characteristic for: a) Diffuse bronchiectasis b) Cystic fibrosis c)
Chronic lung diseases in children Simple choice 1. Finger clubbing is not characteristic for: a) Diffuse bronchiectasis b) Cystic fibrosis c) Bronchiolitis obliterans d) Complicated acute pneumonia e)
More information**Cystic Fibrosis** Notes :
**Cystic Fibrosis** Notes : - the slides are included in the lecture. - everything in Italic is just important things from the old lecture. - It s easy lecture, even it seems long.. GOOD LUCK Cystic fibrosis
More informationCystic Fibrosis. Information for Caregivers
Cystic Fibrosis Information for Caregivers Arkansas Children s Hospital is an accredited Cystic Fibrosis Care Center by the National Cystic Fibrosis Foundation Cystic Fibrosis: Information for Caregivers
More informationCystic Fibrosis New Patient Binder Cystic Fibrosis Center Pediatric Pulmonary Division
An annotated table-of-contents for the Cystic Fibrosis New Patient Binder Pediatric Pulmonary Division Introduction This booklet is a summary of the key points in the detailed and comprehensive information
More informationContents. In this lecture, we will discuss: Tuberculosis. Asthma. Cystic fibrosis. Bronchopulmonary dysplasia. Miss.kamlah
1 Contents In this lecture, we will discuss: Tuberculosis. Asthma. Cystic fibrosis. Bronchopulmonary dysplasia. 2 Tuberculosis (TB) is caused by organism Mycobacterium tuberculosis, which is transmitted
More informationCystic Fibrosis 8/23/2014 GROWTH DEFICIENCY IN CYSTIC FIBROSIS IS
8/23/214 GROWTH DEFICIENCY IN CYSTIC FIBROSIS IS OBSERVABLE AT BIRTH AND PREDICTIVE OF EARLY PULMONARY FUNCTION by Rebecca Joan Nelson Case Western Reserve University Cleveland, Ohio Thesis Advisor: Rebecca
More informationRhianna Cenci, Sodexo Dietetic Intern
Rhianna Cenci, Sodexo Dietetic Intern Objectives Overview of CF and Treatments CF Medical Nutrition Therapy CF Case Study Cystic Fibrosis (CF) Overview Inherited chronic disease Produces unusually thick
More informationCaregiver burden and quality of life of parents of young children with cystic fibrosis
Caregiver burden and quality of life of parents of young children with cystic fibrosis Professor Patricia Fitzpatrick 1 S George 1, R Somerville 1, B Linnane 2, C Fitzgerald 1 1 UCD School of Public Health,
More informationA Place For Airway Clearance Therapy In Today s Healthcare Environment
A Place For Airway Clearance Therapy In Today s Healthcare Environment Michigan Society for Respiratory Care 2015 Fall Conference K. James Ehlen, MD October 6, 2015 Objectives Describe patients who will
More informationNational Horizon Scanning Centre. Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis. April 2008
Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis April 2008 This technology summary is based on information available at the time of research and a limited literature search. It is not
More informationPediatrics Grand Rounds 18 Sept University of Texas Health Science Center. + Disclosure. + Learning Objectives.
Disclosure Dr Donna Willey Courand receives research support from Cystic Fibrosis Therapeutics The Cystic Fibrosis Foundation Children with Special Health Care Needs Cystic Fibrosis 05: Improving Survival
More informationCYSTIC FIBROSIS Risk Factors Epidemiology Pathogenesis Defective protein synthesis (10%) Abnormal protein folding, processing & trafficking
CYSTIC FIBROSIS Risk Factors Caucasian Family history of CF Infection Exposure to allergens and tobacco Epidemiology Carrier frequency of 1 in 25 for Caucasians The most common lethal genetic disease affecting
More informationCF: Information for Case Managers. Cindy Capen MSN, RN Pediatric Pulmonary Division University of Florida
CF: Information for Case Managers Cindy Capen MSN, RN capencl@peds.ufl.edu Pediatric Pulmonary Division University of Florida About your speaker 25+ years in pulmonary Coordinator for CF Center and CF
More informationCystic fibrosis: From the gene to the disease
Cystic fibrosis: From the gene to the disease Christiane Knoop, MD, PhD Institut de Mucoviscidose de l ULB Hôpital Erasme christiane.knoop@erasme.ulb.ac.be Cystic fibrosis «The infant that tastes of salt
More informationCystic Fibrosis the future
Cystic Fibrosis the future Pathophysiologic cascade Abnormal Gene Abnormal CFTR Therapy Gene replacement Protein replacement Gene read through therapy Abnormal sodium chloride & water movement through
More informationBronchiectasis. Examples include: Viral infections (measles, adenovirus, influenza)
Bronchiectasis What is Bronchiectasis? Bronchiectasis (pronounced bron-kee-ek'-tas-is) is a condition of the airways in the lungs. These airways (bronchial tubes) are tubelike structures that branch from
More informationCystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis 5/01/2011 CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE. D ANDERSEN.
1938 OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE. D ANDERSEN. American Journal Diseases Children. : The beginning May 1938: 49 cases 25 20 15 Nos of cases 10 5 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 Age
More informationRespiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician
Respiratory Disease Dr Amal Damrah consultant Neonatologist and Paediatrician Signs and Symptoms of Respiratory Diseases Cardinal Symptoms Cough Sputum Hemoptysis Dyspnea Wheezes Chest pain Signs and Symptoms
More informationLesson Overview. Human Genetic Disorders. Lesson Overview Human Genetic Disorders
Lesson Overview 14.2 Human Genetic Disorders From Molecule to Phenotype There is a direct connection between molecule and trait, and between genotype and phenotype. In other words, there is a molecular
More informationDR. BALDEV S. PRAJAPATI
DR. BALDEV S. PRAJAPATI D. Ped; MD (Ped.); Gold Medalist FIAP; MNAMS. FICMCH HOD & Professor, GCS Medical College, Hospital & Research Centre, Ahmedabad. Popular Teacher Examiner: UG, M.D;DNB Across the
More informationCystic Fibrosis. Advances and Asian Perspective Dr AS Paul 13 October 06
Cystic Fibrosis Advances and Asian Perspective Dr AS Paul 13 October 06 Cystic Fibrosis An Overview Asian Perspective Advances Cystic Fibrosis An Overview Epidemiology and Pathogenesis Most common severe
More informationRespiratory Disorders. Dr Tanya Robertson
Respiratory Disorders Dr Tanya Robertson Aims Overview of respiratory problems in children Diagnosis Management Asthma Cystic fibrosis Why are children different? Immune status Structure and function respiratory
More informationFriday, January 4. Bell Work:
Friday, January 4 Bell Work: Red green colorblindness is an X linked trait and is recessive. A male who is normal marries a woman who is a carrier, what is the phenotypic ratio of their offspring? 1 Genetic
More informationClinical Commissioning Policy Proposition: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)
Clinical Commissioning Policy Proposition: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages) Reference: NHS England E03X05/01 Information Reader Box (IRB) to be inserted on inside
More informationLesson Overview. Human Genetic Disorders. Lesson Overview Human Genetic Disorders
Lesson Overview 14.2 Human Genetic Disorders THINK ABOUT IT Have you ever heard the expression It runs in the family? Relatives or friends might have said that about your smile or the shape of your ears,
More informationCystic Fibrosis. History of Cystic Fibrosis. History of Cystic Fibrosis. Cystic Fibrosis. Salty Kiss
Cystic Fibrosis History of Cystic Fibrosis Salty Kiss Dr Marleen Moens Revalidatiecentrum voor kinderen en jongeren, respiratoire afdeling UZ Gasthuisberg, mucoteam Leuven 1938 Anderson: cystic fibrosis
More informationBasic mechanisms disturbing lung function and gas exchange
Basic mechanisms disturbing lung function and gas exchange Blagoi Marinov, MD, PhD Pathophysiology Department, Medical University of Plovdiv Respiratory system 1 Control of breathing Structure of the lungs
More informationHuman Genetic Disorders. Lesson Overview. Lesson Overview Human Genetic Disorders
Lesson Overview 14.2 Human Genetic Disorders THINK ABOUT IT Have you ever heard the expression It runs in the family? Relatives or friends might have said that about your smile or the shape of your ears,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Liou TG, Adler FR, Cox DR, Cahill BC. Lung transplantation
More informationREFERRAL GUIDELINES RESPIRATORY
REFERRAL GUIDELINES RESPIRATORY Referral Form: The GP Referral Template is the preferred referral tool (previously known as the Victorian Statewide Referral Form) GP Referral Template This tool is housed
More informationThe Cystic Fibrosis Gene. about. CF is one of the most common genetic diseases that cause death in both children and
Gill1 Peter Gill Malory Klocke Research Paper 02 August, 2011 The Cystic Fibrosis Gene Cystic fibrosis, better known as CF, is a genetic disease most people know very little about. CF is one of the most
More informationEach person has a unique set of characteristics, such as eye colour, height and blood group.
1 of 51 2 of 51 What is inheritance? 3 of 51 Each person has a unique set of characteristics, such as eye colour, height and blood group. A person s characteristics are determined by a combination of the
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Cystic Fibrosis Transmembrane Page 1 of 11 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Prime Therapeutics
More informationTEST INFORMATION Test: CarrierMap GEN (Genotyping) Panel: CarrierMap Expanded Diseases Tested: 311 Genes Tested: 299 Mutations Tested: 2647
Ordering Practice Jane Smith John Smith Practice Code: 675 Miller MD 374 Broadway New York, NY 10000 Physician: Dr. Frank Miller Report Generated: 2016-02-03 DOB: 1973-02-19 Gender: Female Ethnicity: European
More informationPediatrics Grand Rounds 13 November University of Texas Health Science Center at San Antonio. Learning Objectives
Nationwide Newborn Screening for Cystic Fibrosis: Finally Creating an Opportunity for All Patients to Have Better Outcomes Philip M Farrell, MD, PhD* University of Wisconsin-Madison *No disclosures other
More informationExam 2 Respiratory Disorders
Exam 2 Respiratory Disorders Common Cold Common Cold Pathology Common Cold Consequences Rhinosinusitis Rhinosinusitis Pathology Rhinosinusitis ostia can close due to Influenza (Flu) Influenza Pathology
More informationCF WORDS TO KNOW. Glossary (v4)
abdomen through adolescents CF WORDS TO KNOW Glossary (v4) A Abdomen Also called the belly. The part of the body below the diaphragm and above the pelvis where the digestive tract, liver, and kidneys are
More informationChapter 16. Lung Abscess. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 16 Lung Abscess 1 EDA PM C AFC RB A B Figure 16-1. Lung abscess. A, Cross-sectional view of lung abscess. B, Consolidation and (C) excessive bronchial secretions are common secondary anatomic alterations
More informationCystic Fibrosis as it relates to the neonate MARIANNE MUHLEBACH, MD PROFESSOR, DEPT. PEDIATRICS UNC CHAPEL HILL
Cystic Fibrosis as it relates to the neonate MARIANNE MUHLEBACH, MD PROFESSOR, DEPT. PEDIATRICS UNC CHAPEL HILL Objectives: At the end of the presentation the listeners will Be able to describe neonatal
More informationClinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)
Clinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages) Reference: NHS England: 16029/P NHS England INFORMATION READER BOX Directorate Medical Operations and
More informationWelcome to Nutrition Management of Cystic Fibrosis by Lolita McLean, MPH, RDN; Connie Martin, MS, RDN; and Claire Stephens, MS, RDN...
Welcome to Nutrition Management of Cystic Fibrosis by Lolita McLean, MPH, RDN; Connie Martin, MS, RDN; and Claire Stephens, MS, RDN...all of Alabama s Children s Rehabilitation Service, or CRS, part of
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Cystic Fibrosis Transmembrane Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Prime Therapeutics
More informationCarole Wegner RN, MSN And Lori Leiser CRT
Airway Clearance Carole Wegner RN, MSN And Lori Leiser CRT Topics Suctioning and suctioning equipment Medications to facilitate t airway clearance Bronchial hygiene modalities Preparing for suctioning
More informationCystic fibrosis and anaesthesia
Marianne Fitzgerald MRCSI FCARCSI Donal Ryan MRCPI FCARCSI FCICM Matrix reference 2A03, 3D00 Key points Cystic fibrosis (CF) is the most common, lethal genetic disease in Caucasians. The Republic of Ireland
More informationCystic Fibrosis. Kevin Imah - Disorder Specialist Ph.D Vanessa Godinez - Genetic Counselor M.D. Study: Samuel Elliott - Parent & Patient
Cystic Fibrosis Kevin Imah - Disorder Specialist Ph.D Vanessa Godinez - Genetic Counselor M.D. Study: Samuel Elliott - Parent & Patient Cystic Fibrosis: A Hereditary Disease!omes "om #e $cysts% #at of&n
More informationThe University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Pulmonary
The University of Arizona Pediatric Residency Program Primary Goals for Rotation Pulmonary 1. GOAL: Diagnose and manage patients with asthma. 2. GOAL: Understand the role of the pediatrician in preventing
More informationUK Cystic Fibrosis Registry. Annual Data Report 2017
UK Cystic Fibrosis Registry Annual Data Report 2017 Published August 2018 UK Cystic Fibrosis Registry 2017 Annual Data Report An at-a-glance version of this report can be found at cysticfibrosis.org.uk/registryreports
More informationBronchitis. Anatomy of the Lungs The lungs allow us to fill our blood with oxygen. The oxygen we breathe is absorbed into our blood in the lungs.
Bronchitis Introduction Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to the lungs. It causes shortness of breath, wheezing and chest tightness as well as a cough that
More informationBMR Be l g i s c h Mu c o v i s c i d o s e Re g i s t e r
The Belgian CYSTIC FIBROSIS Registry Annual Report 2007 BMR Be l g i s c h Mu c o v i s c i d o s e Re g i s t e r RBM Registre Belge de la Mucoviscidose Scientific Institute of Public Health, Brussels
More information2/20/2015. Bob Bleicher, M.D. HoriSun Hospice Lincoln Pulmonary & Critical Care
Bob Bleicher, M.D. HoriSun Hospice Lincoln Pulmonary & Critical Care Chronic Bronchitis Emphysema Pneumonia Pleural effusions (Cancer, CHF, others) Lung Cancer Chronic Bronchiectasis Cystic Fibrosis Lymphangioleiomyomatosis
More informationChapter 3 The Role of Nutrition in CF Care
Chapter 3 The Role of Nutrition in CF Care S. King, N. Saxby & N. Sander Cystic fibrosis is the most common lethal autosomal recessive genetic condition affecting Caucasians 186,187. Over 3500 Australians
More informationTHE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF)
THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF) Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210. Vertex and the Vertex triangle logo are registered trademarks for Vertex
More informationPULMONARY SURFACTANT, ALPHA 1 ANTITRYPSIN INHIBITOR DEFICIENCY, AND CYSTIC FIBROSIS DR. NABIL BASHIR BIOCHEMISTRY/RESPIRATORY SYSTEM
PULMONARY SURFACTANT, ALPHA 1 ANTITRYPSIN INHIBITOR DEFICIENCY, AND CYSTIC FIBROSIS DR. NABIL BASHIR BIOCHEMISTRY/RESPIRATORY SYSTEM Pulmonary surfactant Pulmonary surfactant is (phospholipoprotein) complex
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Moss RB, Flume PA, Elborn JS, et al, on behalf
More informationCystic Fibrosis Foundation Patient Registry 2013
5/9/2015 Targeting CFTR to Treat Cystic Fibrosis: Small Molecule Therapy Mary Ellen Kleinhenz, MD Director, UCSF Adult Cystic Fibrosis Program Professor of Medicine UCSF Division of Pulmonary, Critical
More informationGOALS AND INSTRUCTIONAL OBJECTIVES
October 4-7, 2004 Respiratory GOALS: GOALS AND INSTRUCTIONAL OBJECTIVES By the end of the week, the first quarter student will have an in-depth understanding of the diagnoses listed under Primary Diagnoses
More informationDiseases of the gastrointestinal system. H Awad Lecture 2: small intestine/ part 2 and appendix
Diseases of the gastrointestinal system H Awad Lecture 2: small intestine/ part 2 and appendix Malabsorption most important causes of malabsorption: Celiac disease tropical sprue Lactase deficiency Whipple
More informationChronic Lung Disease in vertically HIV infected children. Dr B O Hare Senior Lecturer in Paediatrics and Child Health, COM, Blantyre
Chronic Lung Disease in vertically HIV infected children Dr B O Hare Senior Lecturer in Paediatrics and Child Health, COM, Blantyre Natural history of HIV in vertically infected children without and with
More informationCystic Fibrosis in Canada
Cystic Fibrosis Canada Cystic Fibrosis in Canada What is cystic fibrosis? Cystic fibrosis (CF) is the most common fatal genetic disease affecting Canadian children and young adults. There is no cure. Cystic
More informationExample of features used to assess asthma (not complete, please see link)
Asthma: diagnosis in adults The 2008 British Thoracic Society guidelinesmarked a subtle change in the approach to diagnosing asthma. This approach is supported in the updated 2011 guidelines. It suggests
More informationGenetic Carrier Testing Cystic Fibrosis (CF) Spinal Muscular Atrophy (SMA) Fragile X Syndrome
Genetic Carrier Testing Cystic Fibrosis (CF) Spinal Muscular Atrophy (SMA) Fragile X Syndrome It s about knowing. Prenatal testing is not about telling you what s wrong, it s knowing that everything is
More informationDisclaimer. Objectives. I can t cough it up! Airway Clearance Therapy. Heather Murgatroyd, RRT, RPSGT Field Clinical Specialist
I can t cough it up! Airway Clearance Therapy Heather Murgatroyd, RRT, RPSGT Field Clinical Specialist 1 Disclaimer Name of presenter: Heather Murgatroyd, BA, RRT, RPSGT Name of employer: RespirTech I
More informationDisclosures. Advances in the Management of Cystic Fibrosis: A Closer Look at the Roles of CFTR Modulation Therapy 10/28/2016
Advances in the Management of Cystic Fibrosis: A Closer Look at the Roles of CFTR Modulation Therapy Susanna A McColley, MD Associate Chief Research Officer Stanley Manne Children s Research Institute
More informationLevine Children s Hospital. at Carolinas Medical Center. Respiratory Care Department
Page 1 of 7 at Carolinas Medical Center 02.04 Pediatric Patient-Centered Respiratory Care Protocol Application of Chest Physical Therapy Created: 1/98 Reviewed: 4/03, 1/05, 6/08 Revised: Purpose: To describe
More informationA GUIDE TO: CYSTIC FIBROSIS FOR HEALTH PROFESSIONALS
A GUIDE TO: CYSTIC FIBROSIS FOR HEALTH PROFESSIONALS CYSTIC FIBROSIS FOR HEALTH PROFESSIONALS Contents 1. INTRODUCTION 03 2. THE CF GENE 04 3. CF DIAGNOSIS AND SCREENING 05 4. CLINICAL MANIFESTATIONS 06
More informationCASE REPORT. 1. Assistant Professor. Department of Paediatrics, Vinayaka Missions Medical College, Karaikal
A CASE OF KARTAGENER SYNDROME Pagadpally Srinivas 1. Assistant Professor. Department of Paediatrics, Vinayaka Missions Medical College, Karaikal CORRESPONDING AUTHOR: Pagadpally Srinivas, 72, Vellai Pillaiyar
More informationCystic Fibrosis Care Guidelines for Challenging Cystic Fibrosis
Cystic Fibrosis Care Guidelines for Challenging Cystic Fibrosis APRIL 2018 Authors Steve Kent MD, CF Clinic Director, Victoria General Hospital (VGH), Victoria Mark Chilvers MD, CF Clinic Director, B.C.
More informationPulmonary Pathophysiology
Pulmonary Pathophysiology 1 Reduction of Pulmonary Function 1. Inadequate blood flow to the lungs hypoperfusion 2. Inadequate air flow to the alveoli - hypoventilation 2 Signs and Symptoms of Pulmonary
More informationCystic fibrosis: From childhood to adulthood. Eitan Kerem Department of Pediatrics and CF Center Hadassah University Hospital Jerusalem Israel
Cystic fibrosis: From childhood to adulthood Eitan Kerem Department of Pediatrics and CF Center Hadassah University Hospital Jerusalem Israel Vas deference H 2 O Cl - Na + H 2 O Na + Cl - Cl - Cl -
More informationAerosol Therapy. Aerosol Therapy. RSPT 1410 Humidity & Aerosol Therapy Part 4
1 RSPT 1410 Humidity & Part 4 Wilkins Chapter 36; p. 801-806 2 Stability: the tendency for aerosol particles to remain in Size: the the particle, the greater the tendency toward stability the the particle,
More informationHAVE YOU RECENTLY MOVED? PLEASE NOTIFY US.
W-F Professional Associates, Inc. 400 Lake Cook Rd., Suite 207 Deerfield, IL 60015 847-945-8050 April 2003 Pharmacy Perspective: Cystic Fibrosis 707-000-03-004-H01 MISSING A LESSON? IT S EASY TO GO TO
More informationEndocrine Complications of Cystic Fibrosis. Marisa Desimone MD SUNY Upstate Medical University Syracuse, NY
Endocrine Complications of Cystic Fibrosis Marisa Desimone MD SUNY Upstate Medical University Syracuse, NY I have no conflicts of interest to disclose Learning Objectives 1. Review the most common endocrine
More informationClinical Commissioning Policy: Ivacaftor for Cystic Fibrosis (named mutations)
Clinical Commissioning Policy: Ivacaftor for Cystic Fibrosis (named mutations) Reference: NHS England: A01/P/c NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients and
More informationRespiratory System. Respiratory System Overview. Component 3/Unit 11. Health IT Workforce Curriculum Version 2.0/Spring 2011
Component 3-Terminology in Healthcare and Public Health Settings Unit 11-Respiratory System This material was developed by The University of Alabama at Birmingham, funded by the Department of Health and
More informationTransformational Treatments. PRESTON W. CAMPBELL, III, M.D. Executive Vice President for Medical Affairs
Transformational Treatments PRESTON W. CAMPBELL, III, M.D. Executive Vice President for Medical Affairs Symptom-based CF Therapies 45 Median Predicted Survival Age of US Patients with Cystic Fibrosis 41
More informationCLINICAL MEDICAL POLICY
Policy Name: Policy Number: Approved By: CLINICAL MEDICAL POLICY Genetic Testing for Cystic Fibrosis MP-006-MD-DE Provider Notice Date: 11/1/2016 Original Effective Date: 12/1/2016 Annual Approval Date:
More information